Now I have a clear picture. Let me finalize my comparative assessment:

- **ProteiNexus (3.67)**: ProteinVista is clearly stronger — more rigorous evaluation, honest failure reporting, cleaner contribution.
- **BindNet (5.67)**: Comparable domain and quality. BindNet has data leakage issues; ProteinVista has circular pretraining. Similar tier.
- **ProteinINR (5.75)**: Comparable. Both have real contributions with evaluation gaps.
- **PPIformer (5.80)**: Slightly stronger than ProteinVista — more self-contained contribution with a new dataset and training scheme.
- **ProteinWorkshop (6.25)**: Benchmark paper, stronger contribution. ProteinVista doesn't reach this level.

**Final assessment**: ProteinVista lands at **5.5** — a borderline accept with real strengths (IC50 result, stratified analysis, compute efficiency, honest GO reporting) but two significant methodological issues: the circular pretraining comparison with ESM-2 and the absence of structure-based baselines. The paper demonstrates that full-atom 3D CNNs are practically viable for protein-ligand prediction, but the evaluation doesn't cleanly isolate the contribution of the 3D structure representation independent of ESM-2 distillation.

---

## Summary
ProteinVista introduces a 3D CNN that voxelizes full-atom protein structures into five-channel density grids and is contrastively pretrained on ~500K AlphaFold-2 structures against ESM-2 embeddings. The model matches or outperforms ESM-2 on three protein-ligand interaction benchmarks (transporter-substrate, enzyme-substrate, and IC50 affinity prediction) while using far less pretraining data (~0.5M vs ~250M sequences) and ~1% of the GPU-hours. An ensemble with ESM-2 further improves binary classification, demonstrating complementarity between sequence and structure representations.

## Strengths
- **Strong, rigorously tested performance on IC50 affinity prediction.** ProteinVista achieves R²=0.69 vs ESM-2_650M's 0.61 (p < 10^-304), and the ensemble degrades to R²=0.68 — confirming that for fine-grained affinity prediction, atom-level geometry provides the dominant signal and sequence-derived signals add noise rather than complementary information. This is the paper's cleanest result.
- **Ensemble gains demonstrate genuine complementarity on binary classification.** On TSP and ESP (Table 1), the ESM-ProteinVista ensemble (91.5% TSP, 93.0% ESP) outperforms both individual models across all metrics, with McNemar's tests confirming significance (p < 10^-13, p < 10^-17). This directly supports the paper's claim that sequence and structure signals are complementary.
- **Honest reporting of failure on GO annotation strengthens credibility.** Section 3.4 shows ProteinVista achieves Fmax=0.57 vs ESM-2's 0.62 on GO molecular-function prediction. Reporting this negative result alongside the positive binding-task results provides a balanced evaluation and correctly identifies when structure encoders add limited value — a rare practice that builds trust.
- **Stratified analysis provides genuine insight into when structure helps.** Binning test proteins by sequence identity, TM-score, and pLDDT (Section 4.1, Figure 2a-d) reveals that ProteinVista excels when structural folds are well-represented in training and on high-confidence AlphaFold-2 predictions. The finding that the ensemble is most complementary on low-identity proteins is a nuanced observation with practical implications.
- **Dramatic compute efficiency.** Despite comparable GFLOPs (415 vs 520 for ESM-2_650M), ProteinVista processes 1000 proteins in 20 seconds vs 426 seconds (A100), attributed to better GPU utilization from the shallow 5-block CNN architecture. Pretraining uses ~1% of ESM-2's GPU-hours.

## Weaknesses

### Fatal
None.

### Major
- **Circular pretraining confounds the central comparison with ESM-2.** ProteinVista is contrastively pretrained to align its embeddings with ESM-2 embeddings (Section 2.3), yet ESM-2 is the primary baseline throughout the paper. This means the comparison is between ESM-2 fine-tuned directly and a model that was first trained to mimic ESM-2 and then fine-tuned — any advantage could arise from the contrastive pretraining + fine-tuning pipeline being a better optimization recipe rather than from 3D structure adding independent predictive value. The Rosetta regression ablation partially mitigates this: replacing contrastive pretraining with Rosetta regression reportedly reduces IC50 R² by only 1.0% (line 170), suggesting structure contributes independently. However, Rosetta-pretrained performance is shown for only one metric (IC50 R²) — never for TSP or ESP, the two benchmarks where the ensemble outperforms and the complementarity claim is strongest. Without Rosetta-pretrained results across all three benchmarks, the paper's core claim that 3D CNNs "outperform sequence transformers" rests on a confounded comparison.

- **No comparison against existing structure-based encoders.** The paper positions itself against GNN-based structure encoders (DeepFRI, GearNet, ESM-GearNet, GPS-Fun) in the introduction (lines 17-25), arguing that these methods lose atom-level detail and that "most investigated protein graph encodings only slightly outperformed the sequence-only ESM-2 baseline" (line 23). Yet none of these appear as baselines. The reader cannot assess whether ProteinVista's full-atom 3D CNN actually advances beyond residue-level GNN encoders, or whether the gains over ESM-2 simply recover ground that existing structure-aware methods already cover. The paper's contribution claim is undersupported without at least one structure-based baseline.

### Minor
- **Rotation robustness is tested only on discrete 90° rotations.** The augmentation covers axis-aligned 90° rotations and mirror reflections (48 discrete orientations), but the paper never evaluates on arbitrary continuous rotations. Since AlphaFold-2 structures have arbitrary orientations and the 6.4% R² drop from reducing 5 views to 1 (Section 4.2) demonstrates that orientation matters substantially, the claim of "rotation-robust representations" overstates what the evidence supports.
- **Numerical inconsistencies between text and Figure 2e.** The text reports a 6.4% R² drop for 1 vs. 5 views while the figure table says ~-5.5%; the text reports 1.0% for Rosetta vs. CL while the figure says ~1.2%; the text reports 0.9% gain for 10 vs. 5 views while the figure says ~1.8%; the text reports -0.1% for no training augmentation while the figure says ~0.4%. None of the ablation numbers match between text and figure, which undermines trust in the precise values.
- **IC50 ensemble degradation is not adequately explained.** On IC50 regression, the ESM-ProteinVista ensemble (R²=0.68) performs worse than ProteinVista alone (R²=0.69). The paper's explanation — that affinity prediction "relies strongly on fine-grained structural detail, leaving little additional information for the sequence model to contribute" (lines 124-125) — explains why the ensemble doesn't help but not why it *harms* performance. A simple average should at worst match the better single model.
- **GO annotation experiment lacks basic experimental details.** Section 3.4 reports Fmax scores with no information about dataset size, train/validation/test splits, or whether the performance difference is statistically meaningful. This makes the negative result hard to interpret.

### Trivial
- The number of Rosetta scores is inconsistent: Section 2.3 (line 73) says 23, while the Discussion (line 219) says 33.

## Nice-to-Haves
- Report Rosetta-pretrained ProteinVista on all three benchmarks (TSP, ESP, IC50) to break the circularity with ESM-2 and provide independent evidence for the core claim.
- Add at least one structure-based GNN baseline (e.g., ESM-GearNet) on the binding benchmarks.
- Test rotation robustness on arbitrary continuous 3D rotations beyond the 48 discrete orientations.
- Resolve numerical inconsistencies between text and Figure 2e.
- Investigate why the IC50 ensemble degrades rather than simply matching the better single model.

## Removed Points
These points are flagged to be removed, treat them with caution:

- **Harsh Critic: "First compute-efficient full-atom 3D CNN" claim vs. 3DCNN_MQA.** The paper's claim explicitly includes "pretrained on large-scale AlphaFold-2 structures" (line 37), which distinguishes it from 3DCNN_MQA (Derevyanko et al., 2018) that predates both AlphaFold-2 and large-scale pretraining. Removed as a strawman reading — the novelty is in scale and pretraining, not in being the first full-atom 3D CNN per se.

- **Harsh Critic: Gaussian density formula typo on line 57.** The formula reads `v⃗ = exp(-‖v⃗ - r⃗‖/σ²)` with v⃗ appearing on both sides. Per review guidelines, formatting artifacts and typos are removed from evaluation — the intended formula (a density kernel) is clear from context and this does not affect the paper's contributions.

- **Strength Finder: "Gaussian density encoding and adaptive boxing are thoughtful design choices."** The strength finder itself notes "These are not claimed as novel contributions." While valid engineering, these implementation choices do not rise to the level of a substantive paper strength for ICLR evaluation.

## Novel Insights
The stratified analysis by sequence identity, structural similarity, and pLDDT (Section 4.1) provides a genuinely useful framework for understanding when structure encoders add value: they help most when structural folds are well-represented in training and when AlphaFold-2 confidence is high. The nuanced finding that ProteinVista outperforms ESM-2 most clearly on high-identity test proteins, yet the ensemble is most complementary on low-identity ones, goes beyond simple accuracy comparisons and offers practical guidance for when to deploy structure-aware models — a contribution that is separable from the particular architecture.

## Suggestions
- Elevate the Rosetta regression pretraining from a one-metric ablation to a full alternative pipeline with results on all three benchmarks. If Rosetta-pretrained ProteinVista still outperforms ESM-2, the paper's core claim stands on independent evidence; if not, the claim should be appropriately narrowed.
- Include at least one structure-based baseline (ESM-GearNet or GPS-Fun) on the binding benchmarks to contextualize the contribution relative to existing structure-aware methods.

## Calibration Anchor Comparison
- **ProteiNexus (3.67)**: ProteinVista is clearly stronger — more rigorous evaluation, honest failure reporting, cleaner contribution.
- **BindNet (5.67)**: Comparable domain. Both have evaluation gaps but real domain results. ProteinVista's circular pretraining issue is different but similarly serious to BindNet's data leakage concerns.
- **ProteinINR (5.75)**: Comparable quality. Both open new directions with evaluation gaps; ProteinVista has stronger headline results but a more confounded core comparison.
- **PPIformer (5.80)**: Slightly stronger — more self-contained contribution (new dataset, novel training scheme).
- **ProteinWorkshop (6.25)**: Benchmark paper with broader impact. ProteinVista is below this level.
- **Round 1 bracket**: 5.0–6.0. Round 2 narrowed to 5.0–5.8. Final score: 5.5.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Accept</decision>